Previous close | 5.94 |
Open | 6.02 |
Bid | 5.93 x N/A |
Ask | 6.14 x N/A |
Day's range | 6.02 - 6.02 |
52-week range | 2.93 - 7.58 |
Volume | |
Avg. volume | 947 |
Market cap | 211.127M |
Beta (5Y monthly) | 1.41 |
PE ratio (TTM) | 16.27 |
EPS (TTM) | 0.37 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 01 Jun 2022 |
1y target est | N/A |
Zinzino, the global health and wellness brand from Scandinavia, has entered into a strategic agreement in Europe to partner with North American ACN, a direct seller of telecommunications, energy, and essential services for homes and businesses, which has decided to wind down its direct selling operations in Europe. The agreement between the companies includes that Zinzino takes over the rights to ACN's European distributor database register free of charge, which will in the future be integrated
The revenue in October for Zinzino's sales markets increased by 22 % and amounted to SEK 156.2 (128.5) million. Faun Pharma's external sales increased by 20 % and amounted to SEK 5.9 (4.9) million. Overall, the Group increased revenues by 22 % to SEK 162.1 (133.4) million compared with the previous year.